Organogenesis Holdings Inc. - Class A (ORGO) Stock

About Organogenesis Holdings Inc. - Class A

Organogenesis Holdings Inc. - Class A is led by CEO Gary S. Gillheeney, employs 869 people, headquartered in US, publicly traded since 2017.

Organogenesis Holdings Inc. - Class A (ORGO) stock trades at $0.99 with a market capitalization of $127.80M. The stock is valued at a negative price-to-earnings (P/E) ratio of -1.62, reflecting a net loss over the last twelve months, price-to-book of 0.59, price-to-sales of 0.37. Over the past 52 weeks the stock has ranged between $0.95 and $7.08, and currently trades 86.0% below its 52-week high.

On profitability, Organogenesis Holdings Inc. - Class A generates a return on equity (ROE) of -24.23% (negative, reflecting a net loss), return on capital employed of -8.34%, an operating margin of 9.95%, a net profit margin of -19.76%.

Organogenesis Holdings Inc. - Class A by the numbers, 2016–2025

Between 2016 and 2025 Organogenesis Holdings Inc. - Class A reported revenue of $0 rising to $563.0M. Compounded, revenue has grown 10.7% a year over five years, 7.7% over three, 16.8% over the last twelve months. Net profit was $37.0M in 2025.

The most recent net margin is -19.76%. On a trailing twelve-month basis to Jun '26, revenue is $456.0M and net profit $-89.0M.

Borrowings stand at $133.0M, cash from operations was $-10.0M in the latest year, positive in 5 of the last 10.

Return on equity has averaged 11.1% over five years, and was 8.5% in the most recent year.

The share price itself has compounded at —% a year over five years, —% over three, —% over the last year. Past price movement is history, not a forecast.

Figures are as reported and in the company's own reporting currency. They describe what has already happened and carry no implication about what follows.

Organogenesis Holdings Inc. - Class A (ORGO) — frequently asked questions